SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 203.92-1.4%12:57 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andreas Helke who wrote (11232)11/16/1997 2:12:00 PM
From: tonyt  Read Replies (1) of 32384
 
> I had already figured out that it is not a good idea to buy Ligand during a rally
> because this stock provides more than enough opportunities to buy on dips.

The general trend is for biotechs to rally in the fall, and drop in the spring, however we may have already seen the highs for biotechs this year. It may be hard to believe, but I don't see fridays intraday low of $13 3/8s for LGND as the floor. Unless we get a rally in the biotechs soon, LGND will break $12 (and if the market gets hit hard due to the middle east, it might even see 10).

> But I bought nonetheless in anticipation of the diabetes deal.

What's your take on the fact that J&J wasn't the rumored partner? Do you feel that it might have been the cause of the negative reaction after the deal was announced, or was it just the typical 'sell on the news' (although the selling has continued well after the news was released). Although there are some folks who refuse to admit it, even the 'Big Boys' are selling now.

--Tony
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext